antimalarials: We have designed, synthesized, and tested a battery of lysyl‐tRNA synthetase inhibitors based on the structure of lysyl‐adenylate, the natural substrate intermediate of the tRNA lysinylation reaction. We show that some of these compounds selectively inhibit Plasmodium apicoplastic lysyl‐tRNA synthetase without inhibiting its human orthologue.
合理设计抗疟疾药物:我们基于赖
氨酰
腺苷酸(tRNA赖
氨酰化反应的天然底物中间体)的结构设计,合成和测试了一系列赖
氨酰tRNA合成酶
抑制剂。我们显示出其中一些化合物选择性抑制疟原虫脂生性赖
氨酰-tRNA合成酶而不抑制其人类直系同源物。